BOSTON — The second day of AdvaMed 2012, hosted by the Advanced Medical Technology Association (AdvaMed; Washington), included a session dealing with the recent guidance for responding to unsolicited inquiries into off-label indications, and many in attendance may have hoped for a promise from FDA that it would fill in the blanks in the December 2011 guidance on this subject. Read More
